Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Immunol., 15 July 2025

Sec. Nutritional Immunology

Volume 16 - 2025 | https://doi.org/10.3389/fimmu.2025.1651209

Correction: Evaluating the predictive effect of vitamin D on clinical outcomes of infliximab-treated Crohn’s disease patients

This article is a correction to:

  1. Evaluating the predictive effect of vitamin D on clinical outcomes of infliximab-treated Crohn's disease patients

    1. Read original article
Jiao ZhengJiao Zheng1Hongping GaoHongping Gao1Yu ZhangYu Zhang1Mingxuan SunMingxuan Sun1Hang SunHang Sun1Ying Pei*Ying Pei2*
  • 1Department of Anorectal, Affiliated Municipal Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
  • 2Department of Endocrinology, Xuzhou Municipal Hospital Affiliated to Xuzhou Medical University, Xuzhou, Jiangsu, China

A Correction on
Evaluating the predictive effect of vitamin D on clinical outcomes of infliximab-treated Crohn’s disease patients

By Zheng J, Gao H, Zhang Y, Sun M, Sun H and Pei Y (2025) Front. Immunol. 16:1578191. doi: 10.3389/fimmu.2025.1578191

Affiliation “Department of Endocrinology, Xuzhou Municipal Hospital Affiliated to Xuzhou Medical University, Xuzhou, Jiangsu, China.” was erroneously omitted for author “Ying Pei”, and was incorrectly listed as “Department of Anorectal, Affiliated Municipal Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China”. This has been corrected to read:

“Jiao Zheng 1, Hongping Gao1, Yu Zhang1, Mingxuan Sun1, Hang Sun1, Ying Pei2.

1. Department of Anorectal, Affiliated Municipal Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.

2. Department of Endocrinology, Xuzhou Municipal Hospital Affiliated to Xuzhou Medical University, Xuzhou, Jiangsu, China

The original version of this article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: Crohn’s disease, vitamin D, infliximab, remission rate, gastroenterology

Citation: Zheng J, Gao H, Zhang Y, Sun M, Sun H and Pei Y (2025) Correction: Evaluating the predictive effect of vitamin D on clinical outcomes of infliximab-treated Crohn’s disease patients. Front. Immunol. 16:1651209. doi: 10.3389/fimmu.2025.1651209

Received: 21 June 2025; Accepted: 30 June 2025;
Published: 15 July 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Zheng, Gao, Zhang, Sun, Sun and Pei. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Ying Pei, cGVpeWluZzI5MDFAMTYzLmNvbQ==

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.